---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-152767"
form_type: "8-K"
ticker: "IKT"
cik: "0001750149"
company_name: "Inhibikase Therapeutics, Inc."
filed_at: "2025-06-30T23:59:59+00:00"
generated_at: "2026-05-18T13:44:15.856656+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Inhibikase stockholders re-elect directors, ratify auditor, approve equity plan amendment at 2025 annual meeting

## Summary
- Amit Munshi and David Canner re-elected as Class II directors with 56.8M and 57.7M votes for, respectively; 3.4M broker non-votes.
- CohnReznick LLP ratified as independent auditor for FY2025: 61.1M votes for, 29k against, no broker non-votes.
- Amendment to 2020 Equity Incentive Plan (evergreen provision) approved: 46.3M for, 11.4M against, 3.4M broker non-votes.
- Annual meeting held June 27, 2025; no other matters voted on.

## SEC filing metadata
- accession: 0001193125-25-152767
- form_type: 8-K
- ticker: IKT
- cik: 0001750149
- company_name: Inhibikase Therapeutics, Inc.
- filed_at: 2025-06-30T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1750149/000119312525152767/0001193125-25-152767-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1750149/000119312525152767/d109611d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-152767
- JSON: https://secwatch.observer/filing/0001193125-25-152767.json
- Plain text: https://secwatch.observer/filing/0001193125-25-152767.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.